Dr. Bernd Jilma

Dr. Bernd Jilma

Medizinische Universität Wien

H-index: 81

Europe-Austria

About Dr. Bernd Jilma

Dr. Bernd Jilma, With an exceptional h-index of 81 and a recent h-index of 43 (since 2020), a distinguished researcher at Medizinische Universität Wien, specializes in the field of Clinical Pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results

Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome

Capillaroscopic differences between primary Raynaud phenomenon and healthy controls indicate potential microangiopathic involvement in benign vasospasms

Thromboelastography in Acute Immunologic Reactions. A Prospective Pilot Study.

Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies

Comparison Evaluation of Automated Nucleated Red Blood Cell Enumeration by Sysmex XN 1000 in Comparison With Microscopic Reference in Children Under 1 Year

Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge

Add-on erythropoietin in autoimmune hemolytic anemia

Dr. Bernd Jilma Information

University

Position

Professor of Clinical Pharmacology and Internal Medicine

Citations(all)

25880

Citations(since 2020)

9548

Cited By

19459

hIndex(all)

81

hIndex(since 2020)

43

i10Index(all)

407

i10Index(since 2020)

231

Email

University Profile Page

Medizinische Universität Wien

Google Scholar

View Google Scholar Profile

Dr. Bernd Jilma Skills & Research Interests

Clinical Pharmacology

Top articles of Dr. Bernd Jilma

Title

Journal

Author(s)

Publication Date

A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results

Eclinicalmedicine

Christian Schoergenhofer

Georg Gelbenegger

Dzenita Hasanacevic

Léa Schöner

Margarete M Steiner

...

2024/1/1

Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome

Pharmaceutics

Thorsten Bischof

Christoph Schaller

Nina Buchtele

Thomas Staudinger

Roman Ullrich

...

2024/2/21

Capillaroscopic differences between primary Raynaud phenomenon and healthy controls indicate potential microangiopathic involvement in benign vasospasms

Vascular Medicine

Sophie Brunner-Ziegler

Eva Dassler

Markus Müller

Marco Pratscher

Nikolaus Franz-Ferdinand Maria Forstner

...

2024/2/9

Thromboelastography in Acute Immunologic Reactions. A Prospective Pilot Study.

Research and Practice in Thrombosis and Haemostasis

Calvin Lukas Kienbacher

Christian Schoergenhofer

Gerhard Ruzicka

Jürgen Grafeneder

Christine Hufnagl

...

2024/4/27

Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies

Miriam M Moser

Christian Schoergenhofer

Bernd Jilma

2024/2/8

Comparison Evaluation of Automated Nucleated Red Blood Cell Enumeration by Sysmex XN 1000 in Comparison With Microscopic Reference in Children Under 1 Year

Journal of Clinical Laboratory Analysis

Sophie Brunner‐Ziegler

Bernd Jilma

Gabriele Grimm

Petra Jilma‐Stohlawetz

2024/4/15

Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge

Thrombosis Research

Andreas Scheuba

Branislav Zagrapan

Luca Martelanz

Vanessa Eder

Nahla Ibrahim

...

2024/1/15

Add-on erythropoietin in autoimmune hemolytic anemia

Blood Advances

Miriam M Moser

Bernd Jilma

2024/3/12

Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease

American Journal of Hematology

Alexander Röth

Wilma Barcellini

Shirley D'Sa

Yoshitaka Miyakawa

Catherine M Broome

...

2023/8

P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 …

HemaSphere

Alexander Röth

Catherine M Broome

Wilma Barcellini

Bernd Jilma

Quentin A Hill

...

2023/8/1

APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke

Frontiers in neurology

Macarena Hernández-Jiménez

Francisco Abad-Santos

Ian Cotgreave

Jaime Gallego

Bernd Jilma

...

2023/2/24

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease

Blood Advances

Georg Gelbenegger

Ulrich Jäger

Michael Fillitz

Christian Schörgenhofer

Christian Sillaber

...

2023/5/23

Switching from cangrelor to prasugrel in patients undergoing percutaneous coronary intervention: the switching antiplatelet-6 (SWAP-6) study

Cardiovascular Interventions

Francesco Franchi

Fabiana Rollini

Luis Ortega-Paz

Latonya Been

Salvatore Giordano

...

2023/10/23

A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in …

Trials

Frederik Haupenthal

Jette Rahn

Fabrizio Maggi

Fanny Gelas

Philippe Bourgeois

...

2023/3/22

Disseminated Intravascular Coagulation in Anaphylaxis

Georg Gelbenegger

Nina Buchtele

Christian Schoergenhofer

Jürgen Grafeneder

Michael Schwameis

...

2023/11/29

Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review

Benjamin Panzer

Christoph W Kopp

Christoph Neumayer

Renate Koppensteiner

Alicja Jozkowicz

...

2023/7/16

P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 …

HemaSphere

Alexander Röth

Sigbjørn Berentsen

Wilma Barcellini

Shirley D’sa

Bernd Jilma

...

2023/8/1

Anti-interleukin-6 antibody clazakizumab in antibody-mediated renal allograft rejection: accumulation of antibody-neutralized interleukin-6 without signs of proinflammatory …

Transplantation

Anita Borski

Farsad Eskandary

Susanne Haindl

Konstantin Doberer

Jakob Mühlbacher

...

2023/2/1

Effects of early introduction of solid foods on nutrient intake in preterm infants during their 1st year of life: a secondary outcome analysis of a prospective, randomized …

Frontiers in Nutrition

Melanie Gsoellpointner

Fabian Eibensteiner

Margarita Thanhaeuser

Robin Ristl

Bernd Jilma

...

2023/5/18

Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1

Urolithiasis

Thomas Boehm

Cristina Martin-Higueras

Eva Friesser

Clara Zitta

Silvia Wallner

...

2023/3/15

See List of Professors in Dr. Bernd Jilma University(Medizinische Universität Wien)

Co-Authors

H-index: 96
Pabinger Ingrid or Pabinger-Faching Ingrid

Pabinger Ingrid or Pabinger-Faching Ingrid

Medizinische Universität Wien

H-index: 89
Nigel Key

Nigel Key

University of North Carolina at Chapel Hill

H-index: 48
Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID  D-6906-2014)

Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014)

Uniwersytet Mikolaja Kopernika w Toruniu

H-index: 36
Florian B Mayr

Florian B Mayr

University of Pittsburgh

H-index: 36
Monika Homoncik

Monika Homoncik

Medizinische Universität Wien

academic-engine